Skip to main content
Premium Trial:

Request an Annual Quote

Bionas, Nexcelom Bioscience

German biotech firm Bionas this week launched the Bionas 2500 analyzing system, a device for in vitro profiling of cellular metabolic activity.
The 2500 measures multiple metabolic parameters, such as acidification, oxygen consumption, and cell adhesion, simultaneously to provide predictive safety pharmacology studies during preclinical drug discovery. The instrument uses a label-free technique based on electronic sensor chips that replace traditional cell culture well plate bottom surfaces.

Nexcelom Bioscience has launched the Cellometer Model Auto T4 Cell Counter, the company said this week.
The Auto T4 automates cell counting using a patent-pending plastic disposable counting chamber. Samples are pipetted into the chamber, and placed into the Auto T4, which connects to a computer. Imaging software measures cell concentration and viability, and cells within a heterogeneous sample can be measured, the company said. The instrument has a footprint of 3.5 inches by 4 inches to “optimize lab space,” and the disposable chamber requires as little as 20 mL of sample, the company said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.